Both of them represent the ER+ luminal A breast cancer subtype, in which RUNX1 is most highly expressed (Fig. 1a), attributable in part to promoter hypomethylation (Supplementary Fig. 2). This evidence concerns the gene RUNX1 and breast cancer.